secwatch.observer — SEC 8-K summary
======================================

Issuer:     GRI Bio, Inc. (GRI)
CIK:        0001824293
Form:       8-K
Filed at:   2025-08-13T23:59:59+00:00
Accession:  0001824293-25-000096
Event type: other
Sentiment:  neutral
Materiality: 0.30
Item codes: 5.02, 5.07, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Shareholders approve 400,000-share increase to GRI Bio's 2018 Equity Incentive Plan
--------------------------------------------------------------------------------

- Shareholders voted 48,362 to 17,889 (179 abstain) to approve the amendment; broker non-votes: 1,023,943.
- Plan increase: 400,000 additional shares of common stock reserved for issuance under the Amended and Restated 2018 Equity Incentive Plan.
- Approximately 43.67% quorum (1,090,373 of 2,496,800 eligible shares) was present at the virtual August 13, 2025 Annual Meeting.
- Directors Roelof Rongen and Camilla V. Simpson elected with 63,031 and 63,581 votes for, respectively (broker non-votes: 1,023,943 each).
- Ratification of WithumSmith+Brown as auditor: 1,072,167 for, 16,553 against, 1,653 abstain (no broker non-votes).

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1824293/000182429325000096/0001824293-25-000096-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1824293/000182429325000096/val-20250813.htm
  HTML page:      https://secwatch.observer/filing/0001824293-25-000096

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer